Mckesson Medical-Surgical Inc. Corporate Office recalls Hylenex recombinant (hyaluronidase) injection, 150 USP units/mL, 4x1 mL Single Dose Vials, Rx only, Manufactured for and
Recalled December 18, 2024 · FDA recall D-0116-2025 · Mckesson Medical-Surgical Inc. Corporate Office
Hazard
cGMP Deviations: Temperature excursion · FDA Class II
Units
5 cartons/20 units each carton
Sold at
Virgina
Description
cGMP Deviations: Temperature excursion
Product
Hylenex recombinant (hyaluronidase) injection, 150 USP units/mL, 4x1 mL Single Dose Vials, Rx only, Manufactured for and marketed by Halozyme, Inc., 12390 El Camino Real San Diego California 92130, Distributed by Antares Pharma, Inc., Ewing, NJ NDC 18657-117-04
Manufacturer(s)
Mckesson Medical-Surgical Inc. Corporate Office
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →